Fig. 3.
Sodium–glucose co-transporter 2 inhibitor (SGLT2i) exposure and reporting rate of SGLT2i-associated DK/DKA. DK diabetic ketosis, DKA diabetic ketoacidosis, DDD defined daily dose
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.